These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21256570)

  • 1. Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia.
    Strope SA; Elliott SP; Smith A; Wei JT; Wilt TJ; Saigal CS;
    Urology; 2011 Mar; 77(3):535-40. PubMed ID: 21256570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.
    Strope SA; Elliott SP; Saigal CS; Smith A; Wilt TJ; Wei JT;
    Urology; 2011 Jul; 78(1):3-9. PubMed ID: 21601254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.
    Collins MM; Barry MJ; Bin L; Roberts RG; Oesterling JE; Fowler FJ
    J Gen Intern Med; 1997 Apr; 12(4):224-9. PubMed ID: 9127226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery.
    Strope SA; Wei JT; Smith A; Wilt TJ; Saigal CS; Elliott SP;
    Urology; 2012 Jul; 80(1):84-9. PubMed ID: 22608799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflation.
    Bellinger AS; Elliott SP; Yang L; Wei JT; Saigal CS; Smith A; Wilt TJ; Strope SA;
    J Urol; 2012 May; 187(5):1739-46. PubMed ID: 22425128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States.
    Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR
    J Urol; 1995 Jul; 154(1):205-6. PubMed ID: 7539861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary care physician versus urologist: how does their medical management of LUTS associated with BPH differ?
    Miner MM
    Curr Urol Rep; 2009 Jul; 10(4):254-60. PubMed ID: 19570485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CROATIAN UROLOGISTS' CLINICAL PRACTICE AND COMPLIANCE WITH GUIDELINES IN THE MANAGEMENT OF NON-NEUROGENIC MALE LOWER URINARY TRACT SYMPTOMS.
    Tomasković I; Tomić M; Nikles S; Neretljak I; Milicić V
    Acta Clin Croat; 2015 Dec; 54(4):453-7. PubMed ID: 27017719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
    Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
    J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France].
    de la Taille A; Desgrandchamps F; Saussine C; Lukacs B; Haillot O
    Prog Urol; 2004 Jun; 14(3):320-5. PubMed ID: 15373173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of healthcare costs for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller E; Matlaga BR; McVary K;
    Int Urol Nephrol; 2022 Nov; 54(11):2797-2803. PubMed ID: 35906501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.
    Barry MJ; Fowler FJ; Bin L; Oesterling JE
    J Urol; 1997 Aug; 158(2):488-91; discussion 492. PubMed ID: 9224330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence.
    Welliver C; MacLachlan LS; Riggs S; Kukreja JB; Miles-Thomas J
    Urol Pract; 2024 Nov; 11(6):950-955. PubMed ID: 39196671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. Canadian Prostate Health Council.
    Ramsey EW; Elhilali M; Goldenberg SL; Nickel CJ; Norman R; Perreault JP; Piercy B; Trachtenberg J
    J Urol; 2000 Feb; 163(2):499-502. PubMed ID: 10647665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
    Fawzy A; Fontenot C; Guthrie R; Baudier MM
    Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
    Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997.
    Gee WF; Holtgrewe HL; Blute ML; Miles BJ; Naslund MJ; Nellans RE; O'Leary MP; Thomas R; Painter MR; Meyer JJ; Rohner TJ; Cooper TP; Blizzard R; Fenninger RB; Emmons L
    J Urol; 1998 Nov; 160(5):1804-7. PubMed ID: 9783961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
    Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.